HOBILPA Trademark

Trademark Overview


On Thursday, September 8, 2022, a trademark application was filed for HOBILPA with the United States Patent and Trademark Office. The USPTO has given the HOBILPA trademark a serial number of 97583719. The federal status of this trademark filing is REGISTERED as of Tuesday, June 25, 2024. This trademark is owned by Ipsen Pharma S.A.S.. The HOBILPA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the prevention and the treatment of cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty diseases or disorders, gynecological disorders, fertility, acromegalia and tumors, hormonal disorders, endocrine disorders, connective tissue disease, blood diseases, gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases, muscle disorders, bone disorders, skeletal disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospam, migraine, bladder pain syndrome, pain, glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; Pharmaceutical preparations containing notably botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other botulinum toxin derivatives for skin...
hobilpa

General Information


Serial Number97583719
Word MarkHOBILPA
Filing DateThursday, September 8, 2022
Status700 - REGISTERED
Status DateTuesday, June 25, 2024
Registration Number7424658
Registration DateTuesday, June 25, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 9, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for use in the prevention and the treatment of cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty diseases or disorders, gynecological disorders, fertility, acromegalia and tumors, hormonal disorders, endocrine disorders, connective tissue disease, blood diseases, gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases, muscle disorders, bone disorders, skeletal disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospam, migraine, bladder pain syndrome, pain, glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; Pharmaceutical preparations containing notably botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other botulinum toxin derivatives for skin care and the treatment of neurological disorders; pharmaceutical preparations containing botulinum toxin with specified components of the toxin haemagglutin complex for skin care and the treatment of neurological disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 26, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIpsen Pharma S.A.S.
Party Type30 - Original Registrant
Legal Entity Type34 - NOT AVAILABLE
AddressBoulogne-Billancourt 92100
FR

Party NameIpsen Pharma S.A.S.
Party Type20 - Owner at Publication
Legal Entity Type34 - NOT AVAILABLE
AddressBoulogne-Billancourt 92100
FR

Party NameIpsen Pharma S.A.S.
Party Type10 - Original Applicant
Legal Entity Type34 - NOT AVAILABLE
AddressBoulogne-Billancourt 92100
FR

Trademark Events


Event DateEvent Description
Monday, September 12, 2022NEW APPLICATION ENTERED
Monday, September 26, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 22, 2023ASSIGNED TO EXAMINER
Monday, June 26, 2023NON-FINAL ACTION WRITTEN
Monday, June 26, 2023NON-FINAL ACTION E-MAILED
Monday, June 26, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 19, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 9, 2024ASSIGNED TO LIE
Friday, February 9, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 9, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 28, 2024ASSIGNED TO EXAMINER
Tuesday, March 5, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 5, 2024EXAMINERS AMENDMENT E-MAILED
Tuesday, March 5, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 5, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, March 5, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 20, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 25, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, June 25, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED